Inclusion Criteria:

- Males and females with clinically diagnosed psoriasis

- Plasma LDL-C 80-190 mg/dL, and TG levels below 400 mg/dL.

- Body mass index (BMI) range will be 22 to 32 kg/m2.

- Subjects must demonstrate an ability to understand dietary procedures and be judged
as compliant and motivated by the investigators.

- Subjects will be permitted to take stable doses of medications (including drugs for
thyroid disease and hypertension)will be permitted if the dose level is maintained
stable throughout the study.

- potential subjects must have stable psoriasis and their treatments must remain
constant throughout the study.

Exclusion Criteria:

- recent (i.e. less than 3 mo) or chronic use of oral hypolipidemic therapy, including
fish oils, or probucol within the last 6 mo

- history of chronic use of alcohol (>2 drinks/d), systemic antibodies,
corticosteroids, androgens, or phenytoin

- subjects on anticoagulant therapy (such as warfarin), taking medications and/or
natural health products known to affect lipid metabolism (cholestyramine, colestipol,
niacin, clofibrate, gemfibrozil, probucol, HMG CoA reductase inhibitors, high dose
dietary supplements or fish oil capsules (>4g/day), guggul, lecithin, evening
primrose oil within the last six month period will be excluded. In addition,
subjects will not be allowed to consume any of these medications during the study

- myocardial infarction, coronary artery bypass, or other major surgical procedures
within the last six months

- recent onset and any history of angina, congestive heart failure, heart disease,
inflammatory bowel disease, pancreatitis, diabetes, lactose intolerance
gastrointestinal, renal, pulmonary, hepatic or biliary disease, or cancer

- moderate or high risk for CAD

- uncontrolled hypertension defined as untreated systolic blood pressure > 160 mmHg
and/or diastolic blood pressure > 100 mmHg

- pregnant, breastfeeding, or planning to become pregnant during the course of the
trial

- bleeding disorder, anemia, or significant recent blood loss/donation

- allergy/sensitivity to any of the ingredients in the study product or placebo

- chronic user of algal products, fiber laxative (greater than 2 doses/wk), or
stimulant laxatives or has a history of eating disorders, exercise greater than 15
miles/wk or 4,000 kcal/wk.